BELITE BIO, INC (BLTE) is a pharmaceutical preparations company incorporated in Cayman Islands, listed on the Nasdaq. With a market capitalization of $6.7 billion, BELITE BIO, INC is a mid-cap company. The stock currently trades at $177.58, down 6.68% today, with a 52-week range of $49.00–$200.00. The company trades at a forward P/E of 114.3x.
No 10-K filings found.